Jefferies analyst David Stanton downgrades Mesoblast (NASDAQ:MESO) from Buy to Hold.
Apple’s Break With Goldman Sachs, iCloud Security Concerns, Vision Pro Cost Cuts And More: This Week In Appleverse
Another bustling weekend has passed in the world of technology, with Apple Inc. (NASDAQ:AAPL) making headlines. The tech giant made…